MX371533B - Composicion de preparacion externa que contiene s-flurbiprofeno. - Google Patents

Composicion de preparacion externa que contiene s-flurbiprofeno.

Info

Publication number
MX371533B
MX371533B MX2017004505A MX2017004505A MX371533B MX 371533 B MX371533 B MX 371533B MX 2017004505 A MX2017004505 A MX 2017004505A MX 2017004505 A MX2017004505 A MX 2017004505A MX 371533 B MX371533 B MX 371533B
Authority
MX
Mexico
Prior art keywords
flurbiprofen
composition containing
external preparation
preparation composition
ester
Prior art date
Application number
MX2017004505A
Other languages
English (en)
Other versions
MX2017004505A (es
Inventor
Kota Matsuki
Takayuki Sato
Yasumasa Uchikawa
Original Assignee
Taisho Pharmaceutical Co Ltd
Tokuhon Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd, Tokuhon Corp filed Critical Taisho Pharmaceutical Co Ltd
Publication of MX2017004505A publication Critical patent/MX2017004505A/es
Publication of MX371533B publication Critical patent/MX371533B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)

Abstract

Un objetivo de la presente invención es el de proporcionar una composición para aplicación externa que contiene S-flurbiprofeno y aceite de menta como potenciador de penetración en la piel, en la cual una disminución dependiente del tiempo en el contenido de S-flurbiprofeno se suprime para mejorar la estabilidad de almacenamiento de S-flurbiprofeno; para lograr este objetivo, al menos un miembro seleccionado del grupo que consiste en un éster que tiene dos ácidos grasos de cadena media enlazados con propilenglicol y un éster que tiene tres ácidos grasos de cadena media enlazados con glicerina se incorpora en una composición para aplicación externa que contiene S-flurbiprofeno y aceite de menta como potenciador de penetración en la piel.
MX2017004505A 2014-10-07 2015-09-15 Composicion de preparacion externa que contiene s-flurbiprofeno. MX371533B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2014206781 2014-10-07
PCT/JP2015/076109 WO2016056356A1 (ja) 2014-10-07 2015-09-15 Ｓ－フルルビプロフェンを含有する外用剤組成物

Publications (2)

Publication Number Publication Date
MX2017004505A MX2017004505A (es) 2017-06-26
MX371533B true MX371533B (es) 2020-01-30

Family

ID=55652977

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017004505A MX371533B (es) 2014-10-07 2015-09-15 Composicion de preparacion externa que contiene s-flurbiprofeno.

Country Status (14)

Country Link
EP (1) EP3205341A4 (es)
JP (2) JP6023358B2 (es)
KR (1) KR20170063700A (es)
CN (1) CN107148269B (es)
AU (1) AU2015329319B2 (es)
BR (1) BR112017005759A2 (es)
CA (1) CA2962034A1 (es)
MX (1) MX371533B (es)
MY (1) MY187120A (es)
PH (1) PH12017500528B1 (es)
RU (1) RU2715907C2 (es)
SG (1) SG11201702334SA (es)
TW (1) TWI717323B (es)
WO (1) WO2016056356A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109843282A (zh) * 2016-10-12 2019-06-04 帝国制药株式会社 水性贴剂
JP6877737B2 (ja) * 2017-03-31 2021-05-26 三笠製薬株式会社 フルルビプロフェン含有含水系貼付剤
GB2591346B (en) 2018-08-10 2023-01-04 Univ Tohoku Production method for polyvalent alcohol ester compounds
CN120022262A (zh) * 2023-11-23 2025-05-23 湖南九典制药股份有限公司 含s-2-(2-氟-4-联苯基)丙酸的药物组合物、贴剂及其制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5829706A (ja) * 1981-08-14 1983-02-22 Toko Yakuhin Kogyo Kk 消炎鎮痛外用剤
JPH06199701A (ja) * 1992-12-29 1994-07-19 Lion Corp 外用消炎鎮痛剤
JP3402682B2 (ja) * 1993-09-08 2003-05-06 サンスター株式会社 歯磨組成物
JP3782834B2 (ja) * 1994-10-26 2006-06-07 株式会社トクホン 鎮痛抗炎症貼付剤
JP2002225883A (ja) * 2001-02-01 2002-08-14 Saitama Daiichi Seiyaku Kk 貼付剤用包装袋
JP4818575B2 (ja) * 2003-06-30 2011-11-16 ライオン株式会社 外用貼付剤及び放射線照射外用貼付剤の変色防止方法
JP2007502823A (ja) * 2003-08-15 2007-02-15 キューエルティー・ユーエスエイ・インコーポレーテッド 接着性および生体侵食性の経粘膜薬物送達システム
US7442399B2 (en) * 2004-06-25 2008-10-28 Kraft Foods Holdings, Inc. Aroma-producing compositions for foods
JP4762565B2 (ja) * 2005-02-08 2011-08-31 久光製薬株式会社 包装袋
JP2009204389A (ja) * 2008-02-27 2009-09-10 Toppan Printing Co Ltd 離型フィルムおよび薬品移行性の評価方法
JPWO2010103844A1 (ja) * 2009-03-11 2012-09-13 興和株式会社 鎮痛・抗炎症剤含有外用剤
KR20110127687A (ko) * 2009-03-11 2011-11-25 코와 가부시키가이샤 진통·항염증제 함유 외용제
KR20110127678A (ko) * 2009-03-11 2011-11-25 코와 가부시키가이샤 진통·항염증제 함유 외용제
GB201010954D0 (en) * 2010-06-29 2010-08-11 Edko Pazarlama Tanitim Ticaret Compositions
JP2012219055A (ja) * 2011-04-07 2012-11-12 Nitto Denko Corp 貼付製剤およびその包装体
JP2013066644A (ja) * 2011-09-26 2013-04-18 Toppan Printing Co Ltd 消炎鎮痛成分低吸着包材
GB201216893D0 (en) * 2012-09-21 2012-11-07 Aesica Pharmaceuticals Ltd Drug substance preparations, pharmaceutical compositions and dosage forms comprising s-(+)-flurbiprofen

Also Published As

Publication number Publication date
CA2962034A1 (en) 2016-04-14
BR112017005759A2 (pt) 2017-12-12
PH12017500528A1 (en) 2017-08-07
TWI717323B (zh) 2021-02-01
RU2715907C2 (ru) 2020-03-04
MX2017004505A (es) 2017-06-26
EP3205341A1 (en) 2017-08-16
RU2017115933A3 (es) 2019-03-06
JP6683443B2 (ja) 2020-04-22
AU2015329319B2 (en) 2018-12-13
TW201625228A (zh) 2016-07-16
MY187120A (en) 2021-09-02
PH12017500528B1 (en) 2017-08-07
CN107148269B (zh) 2020-03-31
WO2016056356A1 (ja) 2016-04-14
SG11201702334SA (en) 2017-05-30
JP2016073623A (ja) 2016-05-12
EP3205341A4 (en) 2018-05-30
RU2017115933A (ru) 2018-11-13
JP6023358B2 (ja) 2016-11-09
CN107148269A (zh) 2017-09-08
AU2015329319A1 (en) 2017-04-20
KR20170063700A (ko) 2017-06-08
JPWO2016056356A1 (ja) 2017-04-27

Similar Documents

Publication Publication Date Title
CO2018005381A2 (es) Inhibidores éster de acc y usos de los mismos
CL2017001046A1 (es) Inhibidoes del bromodominio
CY1119060T1 (el) Ρυθμιστες ενζυμων μεθυλικης τροποποιησης, συνθεσεις και χρησεις αυτων
CU24425B1 (es) Amino-heteroaril-benzamidas como inhibidores de cinasa
CR20150579A (es) Composiciones y métodos para producir cetosis elevada y sostenida
BR112017022209A2 (pt) composição aquosa que compreende éster de ácido omega- aminocarboxílico e álcool graxo e seu uso
UY35300A (es) Formulación de combinación de dos compuestos antivirales
MX362349B (es) Composicion que contiene minoxidil para el crecimiento del pelo.
MX2016016173A (es) Forma de dosis oral solida de compuestos lipofilicos.
ECSP14030779A (es) Inhibidores del nampt
MX375892B (es) Composición que comprende sal de glutamato de acilo como tensoactivo principal o tensoactivo principal aniónico
MX2017001352A (es) Derivados de pirrolidinona como inhibidores de metionina aminopeptidasa 2 (metap-2).
ES2552754T1 (es) Formulaciones de daptomicina y usos de la misma
CR20160433A (es) Nuevos compuestos
BR112016020181A2 (pt) Composições de ácido lipoico éster colina e métodos de uso.
MX2021010716A (es) Composiciones y metodos para inhibir la expresion del gen lect2.
CY1123942T1 (el) Συνθεσεις ωμεγα-3 λιπαρων οξεων για τη θεραπεια ασθενειων που επιφερουν βλαβη στο νευρικο συστημα
AR099500A1 (es) Composición para el desmucilaginado enzimático de aceite
MX371533B (es) Composicion de preparacion externa que contiene s-flurbiprofeno.
MX373023B (es) Composicion que comprende sal de glutamato de acilo como tensoactivo primario o tensoactivo aniónico primario y polimeros estructurantes especificos.
EP3232770A4 (en) Generation of transgenic canola with low or no saturated fatty acids
BR112017008033A2 (pt) composição farmacêutica para administração oral e respectivo processo de preparação
CL2017000207A1 (es) Zwitteriones derivados de disulfuro de carbono
MX390448B (es) Composicion adhesiva.
BR112016013992A2 (pt) Composição cosmética

Legal Events

Date Code Title Description
FG Grant or registration